Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.

We got a term sheet last year that explicitly cut the CMC budget to make the burn look better. Declined.

This is the most honest write-up of seed terms I have read. The part about pro-rata rights is the part founders always skip.

Teaching teenagers: use non-pathogenic yeast, keep everything on plates, and let them design the experiment. The safety risk is boredom-driven improvisation, not the enzyme.

We run exactly this curriculum. Two years, zero incidents, several very good student questions we could not answer.

Trehalose stabilisation is old but the field-deployment data is what makes this worth reading. 40 °C for six weeks is a real number.